Save your time with Corning® HYPER technology

Cell and gene therapies are attracting attention as new drivers of growth in the pharmaceutical and biotech industries. The global market for cell and gene therapies is expected to reach a size of $60 billion by 2026. In particular, the field of anti-cancer therapies is expected to form the largest market and be developed for various indications. With the expansion of the Contract Development and Manufacturing Organization (CDMO) market worldwide, interest in cell and gene therapy companies is also growing stronger. In line with the global market, from research and development to manufacturing, Corning is proud to offer the latest innovative technology to support your advanced therapy applications. From vaccine production to advanced therapy applications. The next generation High Yield PERformance (HYPER) technology lets you grow large quantities of adherent cells in a compact space. The cell production technology uses a unique ultra-thin gas-permeable film to eliminate the air gap within the vessel. This results in a substantial increase in cell growth surface area compared to traditional vessels of comparable cubic footprint. This webinar illustrates the Corning’s HYPER technology to meet scale-up and approach challenge in cell and gene therapy bioprocessing.